Arbutus to Present at Chardan’s 6th Annual Genetic Medicines Conference

September 22, 2022

https://www.globenewswire.com/news-release/2022/09/22/2520893/14025/en/Arbutus-to-Present-at-Chardan-s-6th-Annual-Genetic-Medicines-Conference.html

WARMINSTER, Pa., Sept. 22, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq:ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Company will participate in a fireside chat at Chardan’s 6th Annual Genetic Medicines Conference taking place in New York on Tuesday, October 4, 2022 at 2:30 pm ET.

Read more at globenewswire.com

Related news for (ABUS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.